BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25696794)

  • 21. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma.
    Kim B; Lee ST; Kim HJ; Kim SH
    Ann Lab Med; 2015 Mar; 35(2):187-93. PubMed ID: 25729719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma.
    Dewar R; Andea AA; Guitart J; Arber DA; Weiss LM
    Arch Pathol Lab Med; 2015 Mar; 139(3):338-50. PubMed ID: 25724031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
    Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
    Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric cutaneous lymphomas: a review and comparison with adult counterparts.
    Kempf W; Kazakov DV; Belousova IE; Mitteldorf C; Kerl K
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1696-709. PubMed ID: 25715748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
    Menter T; Dirnhofer S; Tzankov A
    J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
    Green MR; Kihira S; Liu CL; Nair RV; Salari R; Gentles AJ; Irish J; Stehr H; Vicente-Dueñas C; Romero-Camarero I; Sanchez-Garcia I; Plevritis SK; Arber DA; Batzoglou S; Levy R; Alizadeh AA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1116-25. PubMed ID: 25713363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
    Martínez-Banaclocha N; Martínez-Madueño F; Caballé B; Badia J; Blanes M; Bujanda DA; Calvo V; Gómez Codina J; Blanco CQ; Espinosa P; Lavernia J; Arroyo FRG; Risueño MG; Llorca C; Cumeras R; Pulla MP; Gumà J
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An adolescent with primary cutaneous follicle center lymphoma: a case report and literature review.
    Niu WY; Yan XS; Qiao H; Sun YJ; Gu HY; Li GL; Cui ZG; Du J
    Front Oncol; 2023; 13():1273719. PubMed ID: 38023243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data.
    Kurz KS; Kalmbach S; Ott M; Staiger AM; Ott G; Horn H
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment.
    Zhang Y; LeWitt TM; Louissaint A; Guitart J; Zhou XA; Choi J
    J Invest Dermatol; 2023 Feb; 143(2):189-196. PubMed ID: 36163302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.
    Krenitsky A; Klager S; Hatch L; Sarriera-Lazaro C; Chen PL; Seminario-Vidal L
    Am J Clin Dermatol; 2022 Sep; 23(5):689-706. PubMed ID: 35854102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
    Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
    Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Treatment of Primary Cutaneous B-Cell Lymphomas: State of the Art and Perspectives.
    Dumont M; Battistella M; Ram-Wolff C; Bagot M; de Masson A
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32521744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role.
    Pileri A; Agostinelli C; Bertuzzi C; Grandi V; Maio V; Lastrucci I; Santucci M; Pimpinelli N
    Front Oncol; 2020; 10():662. PubMed ID: 32411611
    [No Abstract]   [Full Text] [Related]  

  • 35. Rare presentation of disseminated follicular lymphoma as an ill-defined reticular patch over the scalp and forehead.
    Talebi-Liasi F; Sandhu S
    JAAD Case Rep; 2019 Apr; 5(4):319-322. PubMed ID: 30989099
    [No Abstract]   [Full Text] [Related]  

  • 36. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary cutaneous follicle center cell lymphoma: a case report and literatures review].
    Qiao J; Lu RN; Wang L; Song MY; Wang Z; Zhang ZH; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):328-330. PubMed ID: 29779332
    [No Abstract]   [Full Text] [Related]  

  • 38. Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma.
    Shastri A; Janakiram M; Mantzaris I; Yu Y; Londono JS; Verma AK; Barta SK
    Oncotarget; 2017 Oct; 8(45):78410-78418. PubMed ID: 29108238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
    Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.